For the quarter ending 2025-12-31, INBP made $11,280K in revenue. -$762K in net income. Net profit margin of -6.76%.
| Income Statement | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 |
|---|---|---|---|---|
| Sales, net | 11,280 | 12,689 | 13,045* | 13,947 |
| Cost of sales | 11,251 | 11,670 | 11,828* | 12,396 |
| Gross profit | 29 | 1,019 | 1,217* | 1,551 |
| Selling and administrative expenses | 943 | 856 | 1,003* | 812 |
| Operating (loss) income | -914 | 163 | 214* | 739 |
| Interest income, net | -40 | -33 | -10* | -5 |
| Other expense, net | 0 | - | -85* | 34 |
| Other income (expense), net | 40 | - | -75* | 39 |
| (loss) income before income taxes | -874 | 196 | 139* | 778 |
| Income tax (benefit) expense, net | -112 | 73 | 636* | 167 |
| Net (gain) income | -762 | 123 | -497 | 611 |
| Basic EPS | -0.03 | 0 | -0.016 | 0.02 |
| Diluted EPS | -0.03 | 0 | -0.016 | 0.02 |
| Basic Average Shares | 31,059,610 | 31,059,610 | 30,486,635 | 30,300,720 |
| Diluted Average Shares | 31,059,610 | 31,421,338 | 31,340,548 | 31,514,591 |
INTEGRATED BIOPHARMA INC (INBP)
INTEGRATED BIOPHARMA INC (INBP)